Armata Pharmaceuticals, Inc. (ARMP)

[GALGO]

NEWS WERE GOOD!!!!!

AmpliPhi Biosciences' CEO to Discuss Novel Approaches to Fighting Drug-Resistant Pathogens in Panel at BIO International

10:40 am ET May 31, 2016


AmpliPhi Biosciences Corporation (NYSE MKT: APHB) today announced that M. Scott Salka, AmpliPhi's Chief Executive Officer, will participate in a panel discussion at this year's BIO International Convention.

Mr. Salka will participate alongside panelists from Aequor, Inc., Seres Therapeutics, the NIH's National Institute of Allergy and Infectious Diseases (NIAID) and BioCentury in a panel session titled "If You Can't Beat ‘Em, Join ‘Em: Evolving Approaches to Tackle Resistant Pathogens," as part of the Infectious Diseases & Vaccines Track, Tuesday, June 7, 2016 from 2:15 – 3:15 p.m. PDT in Room West 3004.

The BIO International Convention is taking place from June 6-9, 2016, and will attract biotechnology and pharma leaders to come together for one week of intensive networking to discover new opportunities and promising partnerships. This event covers a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.